Ultrasound for Socket Healing Evaluation
Launched by UNIVERSITY OF MICHIGAN · Aug 23, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Ultrasound for Socket Healing Evaluation," is studying how effective ultrasound is in monitoring the healing process of dental sockets after tooth extractions. Researchers want to compare ultrasound with another imaging method called micro-CT/LASCA to see which one provides better information about how well the socket is healing in patients who are having a tooth removed and then getting a bone graft for a future dental implant.
To participate in this trial, you need to be at least 18 years old and have a tooth that is considered hopeless, meaning it cannot be saved and will require extraction. Participants will undergo the extraction and bone grafting procedure and will be monitored over time as they heal. This study is currently recruiting individuals of all genders, and the goal is to enroll up to 140 participants. If you join, you'll be part of an important effort to improve dental care and healing methods for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients at least 18 years of age and have at least a tooth that is considered hopeless, planned for an extraction and a bone grafting procedure for subsequent dental implant surgery.
- Exclusion Criteria:
- • Patients not willing or not able to have an extraction, bone graft and subsequent implant surgery due to health, finance, or any other reasons.
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Oliver Kripfgans, PhD
Principal Investigator
University of Michigan, Radiology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported